Stomatitis and VEGFR-Tyrosine Kinase Inhibitors (VR-TKIs): A Review of Current Literature in 4369 Patients

BACKGROUND: Multitargeted tyrosine kinase inhibitors (TKIs) represent a new class of target-specific antineoplastic agents. These agents show some specific adverse events such as fatigue/asthenia, anorexia/loss of appetite, dysgeusia, diarrhea/abdominal pain, hypothyroidism, hypertension, myelosuppr...

Descripción completa

Detalles Bibliográficos
Autores principales: Arena, Claudia, Troiano, Giuseppe, De Lillo, Alfredo, Testa, Nunzio F., Lo Muzio, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994328/
https://www.ncbi.nlm.nih.gov/pubmed/29992147
http://dx.doi.org/10.1155/2018/5035217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994328/
https://www.ncbi.nlm.nih.gov/pubmed/29992147
http://dx.doi.org/10.1155/2018/5035217

Ejemplares similares